T-Cell Immunotherapy Market Research Report by Mechanism Of Action (Active Immunotherapy and Passive Immunotherapy), by Product Class (Bispecific Antibodies, Cytokines, Monoclonal Antibodies, and Oncolytic Virus Therapy), by Type of Therapy, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global T-Cell Immunotherapy Market is expected to grow from USD 4,184.98 Million in 2020 to USD 7,606.66 Million by the end of 2025.
2. The Global T-Cell Immunotherapy Market is expected to grow from EUR 3,669.47 Million in 2020 to EUR 6,669.67 Million by the end of 2025.
3. The Global T-Cell Immunotherapy Market is expected to grow from GBP 3,262.17 Million in 2020 to GBP 5,929.35 Million by the end of 2025.
4. The Global T-Cell Immunotherapy Market is expected to grow from JPY 446,644.26 Million in 2020 to JPY 811,824.22 Million by the end of 2025.
5. The Global T-Cell Immunotherapy Market is expected to grow from AUD 6,077.15 Million in 2020 to AUD 11,045.89 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the T-Cell Immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Mechanism Of Action, the T-Cell Immunotherapy Market studied across Active Immunotherapy and Passive Immunotherapy.
Based on Product Class, the T-Cell Immunotherapy Market studied across Bispecific Antibodies, Cytokines, Monoclonal Antibodies, and Oncolytic Virus Therapy.
Based on Type of Therapy, the T-Cell Immunotherapy Market studied across CAR-T, TCR, and TIL.
Based on Indication, the T-Cell Immunotherapy Market studied across B-cell Malignancies, Liver Cancer, Prostate Cancer, and Renal Cell Carcinoma.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the T-Cell Immunotherapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the T-Cell Immunotherapy Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global T-Cell Immunotherapy Market including Adaptimmune Therapeutics, Apac Biotech, Atara Biotherapeutics, Autolus, Bluebird bio, CARsgen Therapeutics, Cellectis, Chimera Bioengineering, Dendreon Pharmaceuticals LLC, Eureka Therapeutics, Gilead Sciences, Inc., Green Cross Corp, Innovative Cellular Therapeutics, Juno Therapeutics, JW CreaGene Co., Ltd, Kite Pharma, Lava Therapeutics, Lion Biotechnologies, Lyell Immunopharma, Nanjing Legend Pharmaceutical & Chemical, Neogene Therapeutics, NeoTX Therapeutics, Novartis AG, Oxford Vacmedix, Poseida Therapeutics, Sinobioway Cell Therapy, TScan Therapeutics, Xenetic Biosciences, Xyphos, and ZIOPHARM Oncology.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the T-Cell Immunotherapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global T-Cell Immunotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global T-Cell Immunotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global T-Cell Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the Global T-Cell Immunotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global T-Cell Immunotherapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global T-Cell Immunotherapy Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global T-Cell Immunotherapy Market is expected to grow from USD 4,184.98 Million in 2020 to USD 7,606.66 Million by the end of 2025.
2. The Global T-Cell Immunotherapy Market is expected to grow from EUR 3,669.47 Million in 2020 to EUR 6,669.67 Million by the end of 2025.
3. The Global T-Cell Immunotherapy Market is expected to grow from GBP 3,262.17 Million in 2020 to GBP 5,929.35 Million by the end of 2025.
4. The Global T-Cell Immunotherapy Market is expected to grow from JPY 446,644.26 Million in 2020 to JPY 811,824.22 Million by the end of 2025.
5. The Global T-Cell Immunotherapy Market is expected to grow from AUD 6,077.15 Million in 2020 to AUD 11,045.89 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the T-Cell Immunotherapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Mechanism Of Action, the T-Cell Immunotherapy Market studied across Active Immunotherapy and Passive Immunotherapy.
Based on Product Class, the T-Cell Immunotherapy Market studied across Bispecific Antibodies, Cytokines, Monoclonal Antibodies, and Oncolytic Virus Therapy.
Based on Type of Therapy, the T-Cell Immunotherapy Market studied across CAR-T, TCR, and TIL.
Based on Indication, the T-Cell Immunotherapy Market studied across B-cell Malignancies, Liver Cancer, Prostate Cancer, and Renal Cell Carcinoma.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the T-Cell Immunotherapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the T-Cell Immunotherapy Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global T-Cell Immunotherapy Market including Adaptimmune Therapeutics, Apac Biotech, Atara Biotherapeutics, Autolus, Bluebird bio, CARsgen Therapeutics, Cellectis, Chimera Bioengineering, Dendreon Pharmaceuticals LLC, Eureka Therapeutics, Gilead Sciences, Inc., Green Cross Corp, Innovative Cellular Therapeutics, Juno Therapeutics, JW CreaGene Co., Ltd, Kite Pharma, Lava Therapeutics, Lion Biotechnologies, Lyell Immunopharma, Nanjing Legend Pharmaceutical & Chemical, Neogene Therapeutics, NeoTX Therapeutics, Novartis AG, Oxford Vacmedix, Poseida Therapeutics, Sinobioway Cell Therapy, TScan Therapeutics, Xenetic Biosciences, Xyphos, and ZIOPHARM Oncology.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the T-Cell Immunotherapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global T-Cell Immunotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global T-Cell Immunotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global T-Cell Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the Global T-Cell Immunotherapy Market?
5. What are the technology trends and regulatory frameworks in the Global T-Cell Immunotherapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global T-Cell Immunotherapy Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type of Therapy Outlook
3.4. Mechanism Of Action Outlook
3.5. Product Class Outlook
3.6. Indication Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased prevalence of cancer and autoimmune diseases
5.1.1.2. Use of cell-based targeted therapies
5.1.1.3. Increased R&D supporting T-cell immunotherapy
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Commercialisation and funding by pharmaceutical companies
5.1.3.2. Attractiveness of off-the-shelf therapies
5.1.4. Challenges
5.1.4.1. Neurologic toxicities and cytokine release syndrome
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY MECHANISM OF ACTION
6.1. Introduction
6.2. Active Immunotherapy
6.3. Passive Immunotherapy
7. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY PRODUCT CLASS
7.1. Introduction
7.2. Bispecific Antibodies
7.3. Cytokines
7.4. Monoclonal Antibodies
7.5. Oncolytic Virus Therapy
8. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY
8.1. Introduction
8.2. CAR-T
8.3. TCR
8.4. TIL
9. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY INDICATION
9.1. Introduction
9.2. B-cell Malignancies
9.3. Liver Cancer
9.4. Prostate Cancer
9.5. Renal Cell Carcinoma
10. AMERICAS T-CELL IMMUNOTHERAPY MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Adaptimmune Therapeutics
14.2. Apac Biotech
14.3. Atara Biotherapeutics
14.4. Autolus
14.5. Bluebird bio
14.6. CARsgen Therapeutics
14.7. Cellectis
14.8. Chimera Bioengineering
14.9. Dendreon Pharmaceuticals LLC
14.10. Eureka Therapeutics
14.11. Gilead Sciences, Inc.
14.12. Green Cross Corp
14.13. Innovative Cellular Therapeutics
14.14. Juno Therapeutics
14.15. JW CreaGene Co., Ltd
14.16. Kite Pharma
14.17. Lava Therapeutics
14.18. Lion Biotechnologies
14.19. Lyell Immunopharma
14.20. Nanjing Legend Pharmaceutical & Chemical
14.21. Neogene Therapeutics
14.22. NeoTX Therapeutics
14.23. Novartis AG
14.24. Oxford Vacmedix
14.25. Poseida Therapeutics
14.26. Sinobioway Cell Therapy
14.27. TScan Therapeutics
14.28. Xenetic Biosciences
14.29. Xyphos
14.30. ZIOPHARM Oncology
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type of Therapy Outlook
3.4. Mechanism Of Action Outlook
3.5. Product Class Outlook
3.6. Indication Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased prevalence of cancer and autoimmune diseases
5.1.1.2. Use of cell-based targeted therapies
5.1.1.3. Increased R&D supporting T-cell immunotherapy
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Commercialisation and funding by pharmaceutical companies
5.1.3.2. Attractiveness of off-the-shelf therapies
5.1.4. Challenges
5.1.4.1. Neurologic toxicities and cytokine release syndrome
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY MECHANISM OF ACTION
6.1. Introduction
6.2. Active Immunotherapy
6.3. Passive Immunotherapy
7. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY PRODUCT CLASS
7.1. Introduction
7.2. Bispecific Antibodies
7.3. Cytokines
7.4. Monoclonal Antibodies
7.5. Oncolytic Virus Therapy
8. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY
8.1. Introduction
8.2. CAR-T
8.3. TCR
8.4. TIL
9. GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY INDICATION
9.1. Introduction
9.2. B-cell Malignancies
9.3. Liver Cancer
9.4. Prostate Cancer
9.5. Renal Cell Carcinoma
10. AMERICAS T-CELL IMMUNOTHERAPY MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Adaptimmune Therapeutics
14.2. Apac Biotech
14.3. Atara Biotherapeutics
14.4. Autolus
14.5. Bluebird bio
14.6. CARsgen Therapeutics
14.7. Cellectis
14.8. Chimera Bioengineering
14.9. Dendreon Pharmaceuticals LLC
14.10. Eureka Therapeutics
14.11. Gilead Sciences, Inc.
14.12. Green Cross Corp
14.13. Innovative Cellular Therapeutics
14.14. Juno Therapeutics
14.15. JW CreaGene Co., Ltd
14.16. Kite Pharma
14.17. Lava Therapeutics
14.18. Lion Biotechnologies
14.19. Lyell Immunopharma
14.20. Nanjing Legend Pharmaceutical & Chemical
14.21. Neogene Therapeutics
14.22. NeoTX Therapeutics
14.23. Novartis AG
14.24. Oxford Vacmedix
14.25. Poseida Therapeutics
14.26. Sinobioway Cell Therapy
14.27. TScan Therapeutics
14.28. Xenetic Biosciences
14.29. Xyphos
14.30. ZIOPHARM Oncology
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ACTIVE IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PASSIVE IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ONCOLYTIC VIRUS THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CAR-T, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TCR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TIL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. GLOBAL T-CELL IMMUNOTHERAPY MARKET: SCORES
TABLE 137. GLOBAL T-CELL IMMUNOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 138. GLOBAL T-CELL IMMUNOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 139. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RANKING
TABLE 140. GLOBAL T-CELL IMMUNOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 141. GLOBAL T-CELL IMMUNOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 142. GLOBAL T-CELL IMMUNOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 143. GLOBAL T-CELL IMMUNOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 144. GLOBAL T-CELL IMMUNOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 145. GLOBAL T-CELL IMMUNOTHERAPY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ACTIVE IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PASSIVE IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ONCOLYTIC VIRUS THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CAR-T, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TCR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TIL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. GLOBAL T-CELL IMMUNOTHERAPY MARKET: SCORES
TABLE 137. GLOBAL T-CELL IMMUNOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 138. GLOBAL T-CELL IMMUNOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 139. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RANKING
TABLE 140. GLOBAL T-CELL IMMUNOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 141. GLOBAL T-CELL IMMUNOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 142. GLOBAL T-CELL IMMUNOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 143. GLOBAL T-CELL IMMUNOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 144. GLOBAL T-CELL IMMUNOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 145. GLOBAL T-CELL IMMUNOTHERAPY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 (USD MILLION)
FIGURE 5. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 (USD MILLION)
FIGURE 6. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL T-CELL IMMUNOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL T-CELL IMMUNOTHERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2025 (%)
FIGURE 16. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2025
FIGURE 18. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ACTIVE IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PASSIVE IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 VS 2025 (%)
FIGURE 21. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2025
FIGURE 23. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY BISPECIFIC ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ONCOLYTIC VIRUS THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 VS 2025 (%)
FIGURE 28. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2025
FIGURE 30. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CAR-T, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TCR, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TIL, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025
FIGURE 36. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL T-CELL IMMUNOTHERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL T-CELL IMMUNOTHERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL T-CELL IMMUNOTHERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY TYPE
FIGURE 1. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL T-CELL IMMUNOTHERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 (USD MILLION)
FIGURE 5. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 (USD MILLION)
FIGURE 6. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL T-CELL IMMUNOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL T-CELL IMMUNOTHERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2025 (%)
FIGURE 16. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MECHANISM OF ACTION, 2025
FIGURE 18. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ACTIVE IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PASSIVE IMMUNOTHERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 VS 2025 (%)
FIGURE 21. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PRODUCT CLASS, 2025
FIGURE 23. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY BISPECIFIC ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CYTOKINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY ONCOLYTIC VIRUS THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 VS 2025 (%)
FIGURE 28. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TYPE OF THERAPY, 2025
FIGURE 30. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY CAR-T, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TCR, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY TIL, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY INDICATION, 2025
FIGURE 36. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY B-CELL MALIGNANCIES, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY LIVER CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL T-CELL IMMUNOTHERAPY MARKET SIZE, BY RENAL CELL CARCINOMA, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM T-CELL IMMUNOTHERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL T-CELL IMMUNOTHERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL T-CELL IMMUNOTHERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL T-CELL IMMUNOTHERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL T-CELL IMMUNOTHERAPY MARKET, BY TYPE
